Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 3Head & Neck 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Neoplasms 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Carcinoma, Renal Cell 1

Interventions

Carboplatin 71pembrolizumab 70Pemetrexed 62Cisplatin 46Nivolumab 28Paclitaxel 27durvalumab 26Specimen Handling 25osimertinib 23Docetaxel 23Magnetic Resonance Spectroscopy 21Gemcitabine 17Cetuximab 15130-nm albumin-bound paclitaxel 15atezolizumab 14amivantamab 14Radiotherapy 12Radiosurgery 12lazertinib 11Ipilimumab 9Bevacizumab 9cemiplimab 8Taxes 8Drug Therapy 8alectinib 7Ramucirumab 7Observation 7Radiation 6Leucovorin 5Immunoglobulin G 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Tyrosine Kinase Inhibitors × 30 days × Clear all
NCT04777994 2026-06-04

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Calico Life Sciences LLC

Phase 1 Recruiting
248 enrolled
GenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasms, Recurrence

NCT03958565 2026-06-03

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

University of Colorado, Denver

Recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03611738 2026-05-15

Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Active not recruiting
21 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡